| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.92▲ | 12.92▲ | 13.00▼ | N/A | N/A |
| MA10 | 12.95▲ | 12.98▼ | 12.86▲ | N/A | N/A |
| MA20 | 12.93▲ | 12.69▲ | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | 56.746▲ | 65.153▲ | N/A | N/A | N/A |
| STOCH | 30.412 | 54.527 | N/A | N/A | N/A |
| WILL %R | -65.517 | -24.051▲ | N/A | N/A | N/A |
| CCI | -28.327 | 22.514 | N/A | N/A | N/A |
|
Tuesday, December 02, 2025 06:16 AM
YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today provided an update ...
|
|
Monday, November 24, 2025 09:53 AM
"Together, these achievements demonstrate YD Bio’s transition from laboratory innovation to patient-ready products, while building a pipeline aimed at novel therapies for serious eye conditions," said ...
|
|
Monday, November 24, 2025 06:06 AM
For consumers, that means easier access to trusted solutions for comfort and clearer vision, which establishes a commercial foundation for YD Bio in ophthalmology that complements ongoing clinical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/12/25 | 12.81 | 13.275 | 12.1149 | 12.96 | 144,707 |
| 02/12/25 | 12.10 | 13.23 | 11.51 | 12.96 | 124,100 |
| 01/12/25 | 11.50 | 12.50 | 10.90 | 12.50 | 123,800 |
|
|
||||
|
|
||||
|
|